Status asthmaticus medical therapy: Difference between revisions

Jump to navigation Jump to search
 
Line 45: Line 45:
====Contraindicated medications====
====Contraindicated medications====


{{MedCondContrAbs|MedCond = Status asthmaticus|Budesonide|Budesonide And Formoterol Fumarate Dihydrate|Flovent|Fluticasone/salmeterol|Mometasone}}
{{MedCondContrAbs|MedCond = Status asthmaticus|Budesonide|Budesonide And Formoterol Fumarate Dihydrate|Formoterol|Flovent|Fluticasone/salmeterol|Mometasone}}


==References==
==References==

Latest revision as of 14:39, 6 October 2014

Status Asthmaticus Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Status Asthmaticus from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Status asthmaticus medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Status asthmaticus medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Status asthmaticus medical therapy

CDC on Status asthmaticus medical therapy

Status asthmaticus medical therapy in the news

Blogs on Status asthmaticus medical therapy

Directions to Hospitals Treating Status asthmaticus

Risk calculators and risk factors for Status asthmaticus medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Initial severity assessment is evaluated using arterial blood gas and pulmonary function test and aggressive therapy is initiated to prevent progression to respiratory failure.

Medical Therapy

  • Non-invasive ventilation using C-PAP or tight-fitting face mask may be used to reduce the work of breathing without intubation.
  • Helium with oxygen mixture has shown to reduce airway resistance and thereby reduce the work of breathing and also improve bronchodilator efficacy.

Therapy Based on the Severity of the Disease Assessed by Arterial Blood Gas Analysis

Stage 1

Stage 2

Stage 3

Stage 4

Contraindicated medications

Status asthmaticus is considered an absolute contraindication to the use of the following medications:

References

  1. Scarfone RJ, Loiselle JM, Joffe MD, Mull CC, Stiller S, Thompson K et al. (2000) A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med 36 (6):572-8. DOI:10.1067/mem.2000.111060 PMID: 11097697
  2. Bessmertny O, DiGregorio RV, Cohen H, Becker E, Looney D, Golden J et al. (2002) A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults. Ann Emerg Med 39 (6):585-91. PMID: 12023699
  3. Glover ML, Machado C, Totapally BR (2002) Magnesium sulfate administered via continuous intravenous infusion in pediatric patients with refractory wheezing. J Crit Care 17 (4):255-8. DOI:10.1053/jcrc.2002.36759 PMID: 12501154
  4. Blitz M, Blitz S, Beasely R, Diner BM, Hughes R, Knopp JA et al. (2005) Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev (2):CD003898. DOI:10.1002/14651858.CD003898.pub2 PMID: 15846687
  5. Press S, Lipkind RS (1991) A treatment protocol of the acute asthma patient in a pediatric emergency department. Clin Pediatr (Phila) 30 (10):573-7. PMID: 1934839

Template:WH Template:WS